The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review

被引:114
作者
Alves, Vera L. [1 ]
Goncalves, Joao L. [1 ]
Aguiar, Joselin [1 ]
Teixeira, Helena M. [2 ,3 ]
Camara, Jose S. [1 ,4 ]
机构
[1] Univ Madeira, CQM Ctr Quim Madeira, Funchal, Portugal
[2] Univ Coimbra, Fac Med, Coimbra, Portugal
[3] Inst Nacl Med Legal & Ciencias Forenses, Coimbra, Portugal
[4] Univ Madeira, Fac Ciencias Exactas & Engn, Campus Univ Penteada, P-9020105 Funchal, Portugal
关键词
Synthetic cannabinoids; cannabis; new psychoactive substances; pharmacology; toxicology; IN-VITRO METABOLISM; PSYCHOACTIVE SUBSTANCES; MASS-SPECTROMETRY; URINARY METABOLITES; AB-FUBINACA; PHARMACOLOGICAL EVALUATION; CANNABIMIMETIC INDOLES; QUANTITATIVE-ANALYSIS; OXIDATIVE-METABOLISM; ADB-FUBINACA;
D O I
10.1080/10408444.2020.1762539
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The word "cannabinoid" refers to every chemical substance, regardless of structure or origin, that joins the cannabinoid receptors of the body and brain and that have similar effects to those produced by theCannabisplant and based on their source of production, cannabinoids can be classified into endocannabinoids, phytocannabinoids and synthetic cannabinoids. Synthetic cannabinoids represent the largest class of drugs detected through the EU Early Warning System with a total of 190 substances notified from 2008 to 2018 and about 280 have been reported worldwide to the United Nations Office on Drugs and Crime. Sprayed on natural herb mixtures with the aim to mimic the euphoria effect of cannabis and sold as "herbal smoking blends" or "herbal incense" under brand names like "Spice" or "K2", synthetic cannabinoids are available from websites for the combination with herbal materials or more recently, for the use in e-cigarettes. Currently labeled as "not for human consumption" to circumvent legislation, their legal status varies by country with many government institutions currently pushing for their control. However, due to the emergence of new substances, it requires a constant update of the list of controlled drugs. Little is known about how these substances work and their toxic effects in humans and the same product could vary not only in the amount and in the type of substance added. In the last years, synthetic cannabinoids have been associated with deaths and acute intoxications in Europe and, despite a range of new measures introduced in this area, continue to represent a challenge to current drug policy models. These synthetic substances are much more potent than natural cannabis, as well as displayed greater efficacy, acting as full agonists at the cannabinoid receptors. It is possible that, along with being highly potent, some may also have long half-lives, potentially leading to a prolonged psychoactive effect. The present work provides a review on existing literature about the development of synthetic cannabinoids as substances of abuse, current patterns of abuse and their legal status, chemical classification, and some pharmacological and toxicological properties.
引用
收藏
页码:359 / 382
页数:24
相关论文
共 188 条
  • [1] The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report)
    Abbate, Vincenzo
    Schwenk, Michael
    Presley, Brandon C.
    Uchiyama, Nahoko
    [J]. PURE AND APPLIED CHEMISTRY, 2018, 90 (08) : 1255 - 1282
  • [2] Advisory Council for the Misuse of Drugs, 2014, 3 GEN SYNTH CANN
  • [3] Targeting the endocannabinoid system: future therapeutic strategies
    Aizpurua-Olaizola, Oier
    Elezgarai, Izaskun
    Rico-Barrio, Irantzu
    Zarandona, Iratxe
    Etxebarria, Nestor
    Usobiaga, Aresatz
    [J]. DRUG DISCOVERY TODAY, 2017, 22 (01) : 105 - 110
  • [4] Alipour Azita, 2019, Ment Health Clin, V9, P93, DOI 10.9740/mhc.2019.03.093
  • [5] Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients
    Altintas, Merih
    Inanc, Leman
    Oruc, Gamze Akcay
    Arpacioglu, Selim
    Gulec, Huseyin
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1893 - 1900
  • [6] Andre CM, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]
  • [7] [Anonymous], 2011, SYNTH CANN HERB PROD
  • [8] [Anonymous], 2016, SYNTHETIC DRUGS OVER
  • [9] [Anonymous], 2009, Understanding the 'Spice' phenomenon
  • [10] [Anonymous], 2019, SYNTH CANN DAT